Clinical Trial Update: Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy [NA]

View source ↗

Summary

A clinical trial is investigating immediate postoperative bevacizumab administration in patients with proliferative diabetic retinopathy undergoing vitrectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Christian Ophthalmic Surgery Expedition Network | Conditions: Proliferative Diabetic Retinopathy - High Risk | NA | Status: RECRUITING